Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-10-21

FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Hospira, Inc)

View source ↗

Summary

FDA approved Hospira's piperacillin/tazobactam combination under an original ANDA application, providing a generic version of the antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piperacillin and tazobactam (Piperacillin and tazobactam)

Snippet

ORIG AP for PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN AND TAZOBACTAM)